Open access
Aug 2026
EP331 - ECE_2704 - Late diagnosis of X-linked hypophosphatemic rickets in an adult: clinical case and experience with burosumab therapy
Burosumab provides significant biochemical and clinical benefits in patients with severe phenotype of XLH in adults, and the introduction of burosumab has changed the treatment paradigm by directly targeting the underlying pathophysiology of phosphate wasting.
Alina Alzhaxina, Kristina Baikadamova, A. Durmanova
· European Journal of Endocrin... · 0 citations